CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45,000 | -55.9% | 38,505 | +0.6% | 0.00% | – |
| Q2 2022 | $102,000 | +628.6% | 38,268 | +1.2% | 0.00% | – |
| Q1 2022 | $14,000 | -84.3% | 37,824 | +30.0% | 0.00% | – |
| Q4 2021 | $89,000 | -52.9% | 29,085 | -31.7% | 0.00% | – |
| Q3 2021 | $189,000 | -14.5% | 42,570 | +11.6% | 0.00% | – |
| Q2 2021 | $221,000 | -7.5% | 38,140 | +12.9% | 0.00% | -100.0% |
| Q1 2021 | $239,000 | +81.1% | 33,794 | +22.6% | 0.00% | – |
| Q4 2020 | $132,000 | -56.6% | 27,566 | -44.3% | 0.00% | -100.0% |
| Q3 2020 | $304,000 | +19.2% | 49,504 | +30.4% | 0.00% | 0.0% |
| Q2 2020 | $255,000 | +35.6% | 37,956 | +33.1% | 0.00% | 0.0% |
| Q1 2020 | $188,000 | – | 28,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |